3.18.20 | Coronavirus
SWHR Urges Inclusion of Pregnant and Lactating Women in COVID-19 Research
SWHR and other members of the Coalition to Advance Maternal Therapeutics (CAMT) urged the National Institutes of Health (NIH) and […]
2.27.20 | Research and Clinical Trials
RESCHEDULED: Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials
The Duke-Margolis Center for Health Policy is convening a public meeting to discuss the need for clinical research in pregnant women as well as scientific and ethical considerations for the inclusion of this complex population in clinical trials.
2.21.20 | Research and Clinical Trials
Women Make Up 72% of Study Participants for FDA-Approved New Drugs in 2019
SWHR is thrilled with the news that women accounted for 72% of all clinical trial participants for FDA-approved new drugs in 2019.
1.29.20 | Research and Clinical Trials
Advancing Women’s Health Requires the Study of Sex and Gender Differences
Women’s Health Research Day celebrates the day that NIH’s policy requiring inclusion of sex as a biological variable in research took effect.
10.31.19 | Research and Clinical Trials
Report: Cures Act Pushes Women’s Health Research Forward
SWHR and FasterCures, a center of the Milken Institute, released a report outlining the positive changes for women’s health research from the 21st Century Cures Act.
10.22.19 | Policy
SWHR Urges Women’s Health Focus in U.S. Biotechnology Investment
In a letter to the White House Office of Science and Technology Policy (OSTP), SWHR recommended the government prioritize biotechnology […]
9.12.19 | Research and Clinical Trials
Are NIH Policies Unintentionally Impeding Women’s Health Research?
While NIH policies intend to correct imbalances in studying females, one researcher argues that the new movement on including sex as a biological variable has backfired in implementation.
7.24.19 | Policy
SWHR Letter in Support of PRGLAC Task Force
In a letter to the Secretary of Health and Human Services, SWHR expressed its concerns about the future status of […]
7.11.19 | Research and Clinical Trials
SWHR Submits Comments to FDA on Pregnancy and Lactation Draft Guidance
SWHR submitted comments to the FDA in response to draft guidance on considerations for pregnancy safety and lactation studies.
7.8.19 | Policy
SWHR Praises FDA Draft Guidance on Lactation Study Design
SWHR sent comments to the Food and Drug Administration (FDA) regarding the agency’s new draft guidance on pre- or post-market […]
